NRC Health NRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.95% | 3.98% | 3.73% | -4.64% | -3.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.95% | 3.98% | 3.73% | -4.64% | -3.38% |
| Cost of Revenue | 23.98% | 4.55% | 4.51% | -2.89% | -18.95% |
| Gross Profit | 3.68% | 3.63% | 3.24% | -5.75% | 8.24% |
| SG&A Expenses | -1.84% | 78.34% | 29.58% | -30.63% | 11.68% |
| Depreciation & Amortization | -5.79% | 21.76% | 40.66% | 41.49% | 41.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.75% | 37.43% | 17.15% | -11.91% | -3.48% |
| Operating Income | 15.12% | -100.95% | -35.21% | 15.43% | -3.03% |
| Income Before Tax | 18.00% | -880.90% | -43.30% | -63.17% | -14.02% |
| Income Tax Expenses | 25.43% | -282.53% | -40.24% | -36.46% | 33.77% |
| Earnings from Continuing Operations | 14.12% | -2,997.17% | -44.32% | -72.59% | -27.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.12% | -2,997.17% | -44.32% | -72.59% | -27.53% |
| EBIT | 15.12% | -100.95% | -35.21% | 15.43% | -3.03% |
| EBITDA | 10.50% | -79.51% | -23.67% | 18.92% | 4.27% |
| EPS Basic | 19.83% | -1,686.90% | -43.75% | -72.52% | -24.73% |
| Normalized Basic EPS | 20.20% | -119.63% | -40.22% | 16.92% | -7.80% |
| EPS Diluted | 16.67% | -1,401.00% | -44.00% | -74.40% | -24.94% |
| Normalized Diluted EPS | 19.30% | -119.63% | -40.55% | 16.89% | -7.71% |
| Average Basic Shares Outstanding | -1.83% | -2.86% | -5.11% | -6.71% | -6.71% |
| Average Diluted Shares Outstanding | -1.10% | -2.86% | -4.63% | -6.67% | -6.80% |
| Dividend Per Share | 33.33% | 33.33% | 33.33% | 33.33% | 0.00% |
| Payout Ratio | 0.12% | 0.96% | 1.35% | 2.49% | 0.34% |